Prepositioned Medical Countermeasures for the Public

Type: Consensus Study
Topics: Biomedical and Health Research, Public Health
Board: Board on Health Sciences Policy

Activity News and Announcements

Activity Description

In response to a request from the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), the IOM will convene an ad hoc committee of subject matter experts to inform the use of prepositioned medical countermeasures (MCM) for the public. More specifically, the ad hoc committee will focus on prepositioning antibiotics for protection against a terrorist attack using Bacillus anthracis or similar pathogens, producing a report that will:

  • Consider the role of prepositioned medical countermeasures for the public (e.g., prepositioning at home, local stockpiles, and workplace caches) within an overall MCM dispensing strategy that includes traditional MCM dispensing and distribution strategies such as PODs, taking into account both logistical and non-logistical factors (e.g., safety and ethics).
  • Identify and describe key factors and variables that should be included in a strategy for prepositioning MCM for the public (e.g., population demographics, threat status, and proximity to high-value targets, proximity to healthcare facilities).
  • Discuss preliminary considerations for the development of an incremental and phased MCM prepositioning strategy.
  • Based on available evidence, describe economic advantages and disadvantages of various MCM prepositioning strategies for the public.

Previous Meetings for this Activity

View All Previous Meetings